[PDF][PDF] Anti-tumor necrosis factor therapy is not associated with post-operative infection: results from prospective cohort of ulcerative colitis and Crohn's disease …
BL Cohen, P Fleshner, SV Kane, HH Herfarth… - …, 2019 - academia.edu
Background: Patients with inflammatory bowel disease (IBD) frequently require surgery
despite the use of effective therapies including anti-Tumor Necrosis Factor agents (anti …
despite the use of effective therapies including anti-Tumor Necrosis Factor agents (anti …
Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra …
BL Cohen, P Fleshner, SV Kane, HH Herfarth… - Gastroenterology, 2022 - Elsevier
Background & Aims Whether preoperative treatment of inflammatory bowel disease (IBD)
with tumor necrosis factor inhibitors (TNFis) increases the risk of postoperative infectious …
with tumor necrosis factor inhibitors (TNFis) increases the risk of postoperative infectious …
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease: a systematic review and meta-analysis
Objective To assess the impact of inflammatory bowel disease (IBD) medications on
postoperative infection risk within 30 days of surgery. Methods We searched multiple …
postoperative infection risk within 30 days of surgery. Methods We searched multiple …
Association of preoperative anti–tumor necrosis factor therapy with adverse postoperative outcomes in patients undergoing abdominal surgery for ulcerative colitis
AS Kulaylat, AN Kulaylat, EW Schaefer, A Tinsley… - JAMA …, 2017 - jamanetwork.com
Importance Despite the increasing use of anti–tumor necrosis factor (TNF) therapy in
ulcerative colitis, its effects on postoperative outcomes remain unclear, with many patients …
ulcerative colitis, its effects on postoperative outcomes remain unclear, with many patients …
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis
V Billioud, AC Ford, ED Tedesco… - Journal of Crohn's …, 2013 - academic.oup.com
Background and aims: About one-third of inflammatory bowel disease (IBD) patients still
require surgery. A growing number of them receive anti-tumor necrosis factor (TNF) therapy …
require surgery. A growing number of them receive anti-tumor necrosis factor (TNF) therapy …
Pre‐operative use of anti‐TNF‐α agents and the risk of post‐operative complications in patients with ulcerative colitis – a nationwide cohort study
BM Nørgård, J Nielsen, N Qvist… - Alimentary …, 2012 - Wiley Online Library
Background It is still controversial whether pre‐operative anti‐tumour necrosis factor‐alpha
(anti‐TNF‐α) agents increase post‐operative complications in patients with ulcerative colitis …
(anti‐TNF‐α) agents increase post‐operative complications in patients with ulcerative colitis …
Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications
H Kunitake, R Hodin, PC Shellito, BE Sands… - Journal of …, 2008 - Springer
Purpose The impact of infliximab (IFX) on postoperative complications in surgical patients
with Crohn's disease (CD) and ulcerative colitis (UC) is unclear. We examined a large …
with Crohn's disease (CD) and ulcerative colitis (UC) is unclear. We examined a large …
Preoperative anti–tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications …
E Zittan, R Milgrom, GW Ma… - Inflammatory bowel …, 2016 - academic.oup.com
Background There are conflicting data regarding the effect of previous exposure to anti–
tumor necrosis factor (anti-TNF) therapy on complication rates after pelvic pouch surgery for …
tumor necrosis factor (anti-TNF) therapy on complication rates after pelvic pouch surgery for …
The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery
C Lau, M Dubinsky, G Melmed, E Vasiliauskas… - Annals of …, 2015 - journals.lww.com
Objective: Assess the impact of preoperative serum antitumor necrosis factor-α (anti-TNFα)
drug levels on 30-day postoperative morbidity in inflammatory bowel disease (IBD) patients …
drug levels on 30-day postoperative morbidity in inflammatory bowel disease (IBD) patients …
Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients
A Syed, RK Cross, MH Flasar - … journal of the American College of …, 2013 - journals.lww.com
OBJECTIVES: Anti-tumor necrosis factor (anti-TNF) therapy effects on postoperative
complications in Crohn's disease (CD) patients are unclear. We examined a retrospective …
complications in Crohn's disease (CD) patients are unclear. We examined a retrospective …